Our Team

A global team of scientists, clinicians, and entrepreneurs united by precision medicine.

Wahid AWAD

Wahid AWAD, Ph.D | MBA

CEO & Founder

Dr. Wahid Awad is the Founder and CEO of Rosetta Omics, a deeptech healthcare startup pioneering the integration of spatial multiomics and AI to accelerate precision medicine in oncology. With academic and professional experience spanning 13 countries across five continents, he combines a global scientific, business, and cultural perspective to tackle complex challenges in life sciences and healthcare. He serves as Executive Board Member of Paris Saclay Cancer Cluster, Medicen Paris Region and ESCP Business School Alumni Association. He holds a Ph.D. from the United States, a postdoctoral fellowship from France, and an Executive MBA from ESCP Business School.

LinkedIn
Matteo OLDANI

Matteo OLDANI, MBA

CFO

Matteo Oldani is a Strategic CFO at Rosetta Omics, supporting the company's mission to advance cancer precision medicine through multi-omics profiling and AI. He is Associate Partner at YOURgroup, Italy's leading C-Level Executive group, and a member of ANDAF. He specializes in finance, sustainability, organizational transformation and strategy. Matteo holds an Executive MBA from ESCP, the CFA Certificate in Sustainable Investing, and is certified in Neuro-Linguistic Programming (NLP).

Noah SULTAN

Noah SULTAN, Ph.D

Chief Data Officer

Noah Sultan is a data science expert with a PhD in machine learning and more than 10 years of experience in AI and ML. His career began in academia, where he developed DNA motif discovery software at the French National Institute for Agriculture, Food and the Environment. Since then, he has designed and built multiple AI solutions end-to-end, including backend, frontend, deployment, hosting, and tracking. With professional experience across France, Germany, Italy, and Egypt, he brings a global perspective and adaptability to every project.

Aurore DUCAMP

Aurore DUCAMP

Biotechnology Engineer

Aurore is pursuing a Master's in Biotechnology at Sup'Biotech, Paris. She has developed hands-on experience in quality control and analytical methods, combining scientific rigor with project coordination. Aurore brings a proactive mindset and a strong interest in driving innovation in health and precision medicine.

LinkedIn

Hover any card to read the full bio.

Our Advisors

Internationally recognised experts supporting our scientific, clinical, and business strategy.

Oncologists

Dr. Alice Boilève

Dr. Alice Boilève

Head of Digestive Oncology Clinic, INSERM & Gustave Roussy

Dr. Maximiliano Gelli

Dr. Maximiliano Gelli

Surgical HPB Oncologist & Transplant Surgeon, Gustave Roussy

Dr. Hatem Azim

Dr. Hatem Azim

Oncologist & Chief Medical Officer at multiple companies

Dr. Antoine Hollebecque

Dr. Antoine Hollebecque

Médecin Praticien des CLCC, Gustave Roussy

Onco Surgeons

Dr. Léonor Benhaim

Dr. Léonor Benhaim

Gastrointestinal Surgeon, Gustave Roussy, Member of Translational Research at INSERM

Dr. Stylianos Tzedakis

Dr. Stylianos Tzedakis

Associate Surgery, Hepatobiliary, Digestive and Endocrine, Hôpital Cochin (APHP)

Clinical Experts

Prof. Magali Svrcek

Prof. Magali Svrcek

Professor, Centre Léon Bérard (CLB), Lyon

Ana María Fernandez

Ana María Fernandez

MBA, Director of Clinical Operations, APICES, Spain

Clara Hengeveld

Clara Hengeveld

Associate Director of Project Management, Simbec-Orion (Clinical CRO)

Pathologists

Dr. Pierre Sohier

Dr. Pierre Sohier

Pathologist, AP-HP Hôpital Cochin – Port-Royal (Paris)

Dr. Mohamed Amine Bani

Dr. Mohamed Amine Bani

Medical Biology & Pathology, Gustave Roussy

Technology & AI

Tanya Aneichyk

Tanya Aneichyk

CEO of OmicsChart, Omics & Biomarkers in Oncology Drug Development

Stephane Gerart, PhD

Stephane Gerart, PhD

Deputy CSO/CIO, Oncodesign Precision Medicine

Max Kraner, PhD MBA

Max Kraner, PhD MBA

Head of Mass Spectrometry, Novo Nordisk, Germany

Pharma, Medtech & Academics

Caroline Orefice

Caroline Orefice

PhD | MBA, General Manager, Cell & Gene Therapies, Novartis

Abderrahim Lachgar, PhD

Abderrahim Lachgar, PhD

Co-founder of Apmonia Therapeutics & CEO of Par'Immune

Gregory McGuinness, PhD

Gregory McGuinness, PhD

CEO of Inanovate Inc, building companies in Pharma & diagnostics

Vincent Makaterre

Vincent Makaterre

PhD | MBA, VP, BD & Project Portfolio at Idorsia, Switzerland

Prof. Berta Cillero Pastor

Prof. Berta Cillero Pastor

PhD, Group leader, Maastricht University, Netherlands

Moheb Karkera, MBA

Moheb Karkera, MBA

Commercial Excellence Manager, Guerbet

Dr. Dominique Bagnard

Dr. Dominique Bagnard

PhD, Neuroscientist, Professor at University of Strasbourg. Expert in Neurobiology, Biomarkers & Drug Design

Finance & Business

Vittorio De Pedys

Vittorio De Pedys

Professor of Finance and Management, ESCP Business School, Italy

Fahmi Ben Abdelkader

Fahmi Ben Abdelkader

Professor of Finance & Academic Director of the Executive Master in International Wealth Management, ESCP

Anne De Landsheer

Anne De Landsheer

Managing Director, Peak Lifecycles

Philip Morisky, MBA

Philip Morisky, MBA

CEO, Adherence (USA)

Farid Bouzidi

Farid Bouzidi

Senior Partner at BDC, Managing Director Fybden, Biotech Entrepreneur, Switzerland

Murillo Bacci

Murillo Bacci

Value Growth, Transformation & Customer Satisfaction, Supply Chain, Operations & Service, ESCP